Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
US-2019352310-A1 · Nov 21, 2019 · US
Benzimidazoles; Hydrogenated benzimidazoles
Benzimidazoles; Hydrogenated benzimidazoles · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D235/04 |
| Official title | Benzimidazoles; Hydrogenated benzimidazoles |
| Display label | Benzimidazoles; Hydrogenated benzimidazoles |
| Total patents | 126 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 11 |
| 2016 | 12 |
| 2017 | 16 |
| 2018 | 19 |
| 2019 | 13 |
| 2020 | 11 |
| 2021 | 15 |
| 2022 | 7 |
| 2023 | 12 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Preparation process for high-purity dabigatran etexilate
US-2019152945-A1 · May 23, 2019 · US
Piperidine compounds, pharmaceutical composition comprising the same and its use
US-10144709-B2 · Dec 4, 2018 · US
Organic electroluminescent materials and devices
US-10135008-B2 · Nov 20, 2018 · US
Zeolitic imidazolate framework materials, their synthesis and use
US-2018273390-A1 · Sep 27, 2018 · US
Heterocyclic compound
US-10081634-B2 · Sep 25, 2018 · US
FLT3 receptor antagonists
US-10065937-B2 · Sep 4, 2018 · US
NOVEL TNFalpha STRUCTURE FOR USE IN THERAPY
US-2018231562-A1 · Aug 16, 2018 · US
2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors
US-10039755-B2 · Aug 7, 2018 · US
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US-10035763-B2 · Jul 31, 2018 · US
Mechanism of action
US-2018203016-A1 · Jul 19, 2018 · US
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US-10017471-B2 · Jul 10, 2018 · US
Fused imidazole and pyrazole derivatives as modulators of TNF activity
US-10004737-B2 · Jun 26, 2018 · US
Antibody
US-2018171008-A1 · Jun 21, 2018 · US
Antibody epitope
US-2018172701-A1 · Jun 21, 2018 · US
Modulator assay
US-2018172702-A1 · Jun 21, 2018 · US
Novel benzimidazole compound and medical use thereof
US-2018170881-A1 · Jun 21, 2018 · US
2-(azaindol-2-yl) benzimidazoles as pad4 inhibitors
US-2018161316-A1 · Jun 14, 2018 · US
Imidazopyrazines and pyrazolopyrimidines and their use as ampa receptor modulators
US-2018118751-A1 · May 3, 2018 · US
Benzimidazole and imadazopyridine carboximidamide compounds
US-9951065-B2 · Apr 24, 2018 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D235/04?
- CPC C07D235/04 is the Cooperative Patent Classification code for “Benzimidazoles; Hydrogenated benzimidazoles.”
- How many patents are filed under CPC C07D235/04 (Benzimidazoles; Hydrogenated benzimidazoles)?
- Our database includes 126 publications tagged with this CPC code.
- Is patent activity under CPC C07D235/04 growing?
- Publication counts under this code: 3 in 2024 vs 6 in 2025 (latest complete years).